Literature DB >> 31164433

Nanoparticle diffusion in spontaneously expectorated sputum as a biophysical tool to probe disease severity in COPD.

Jane F Chisholm1,2, Siddharth K Shenoy1,3, Julie K Shade1,4, Victor Kim5, Nirupama Putcha6, Kathryn A Carson7, Robert Wise6, Nadia N Hansel6, Justin S Hanes1,2,3,4,8, Jung Soo Suk1,2,3,8, Enid Neptune9,8.   

Abstract

Perturbations in airway mucus properties contribute to lung function decline in patients with chronic obstructive pulmonary disease (COPD). While alterations in bulk mucus rheology have been widely explored, microscopic mucus properties that directly impact on the dynamics of microorganisms and immune cells in the COPD lungs are yet to be investigated.We hypothesised that a tightened mesh structure of spontaneously expectorated mucus (i.e. sputum) would contribute to increased COPD disease severity. Here, we investigated whether the mesh size of COPD sputum, quantified by muco-inert nanoparticle (MIP) diffusion, correlated with sputum composition and lung function measurements.The microstructure of COPD sputum was assessed based on the mean squared displacement (MSD) of variously sized MIPs measured by multiple particle tracking. MSD values were correlated with sputum composition and spirometry. In total, 33 samples collected from COPD or non-COPD individuals were analysed.We found that 100 nm MIPs differentiated microstructural features of COPD sputum. The mobility of MIPs was more hindered in sputum samples from patients with severe COPD, suggesting a tighter mucus mesh size. Specifically, MSD values inversely correlated with lung function.These findings suggest that sputum microstructure may serve as a novel risk factor for COPD progression and severity.
Copyright ©ERS 2019.

Entities:  

Mesh:

Year:  2019        PMID: 31164433      PMCID: PMC8081045          DOI: 10.1183/13993003.00088-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  55 in total

Review 1.  Mucus clearance as a primary innate defense mechanism for mammalian airways.

Authors:  Michael R Knowles; Richard C Boucher
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

2.  Reduced three-dimensional motility in dehydrated airway mucus prevents neutrophil capture and killing bacteria on airway epithelial surfaces.

Authors:  Hirotoshi Matsui; Margrith W Verghese; Mehmet Kesimer; Ute E Schwab; Scott H Randell; John K Sheehan; Barbara R Grubb; Richard C Boucher
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

Review 3.  Mucin overproduction in chronic inflammatory lung disease.

Authors:  Hans-Peter Hauber; Susan C Foley; Qutayba Hamid
Journal:  Can Respir J       Date:  2006-09       Impact factor: 2.409

Review 4.  Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group.

Authors:  J E Repine; A Bast; I Lankhorst
Journal:  Am J Respir Crit Care Med       Date:  1997-08       Impact factor: 21.405

5.  A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue.

Authors:  Elizabeth A Nance; Graeme F Woodworth; Kurt A Sailor; Ting-Yu Shih; Qingguo Xu; Ganesh Swaminathan; Dennis Xiang; Charles Eberhart; Justin Hanes
Journal:  Sci Transl Med       Date:  2012-08-29       Impact factor: 17.956

6.  Deaths: preliminary data for 2011.

Authors:  Donna L Hoyert; Jiaquan Xu
Journal:  Natl Vital Stat Rep       Date:  2012-10-10

Review 7.  Epithelial mucus-hypersecretion and respiratory disease.

Authors:  Henry Danahay; Alan D Jackson
Journal:  Curr Drug Targets Inflamm Allergy       Date:  2005-12

Review 8.  PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.

Authors:  Jung Soo Suk; Qingguo Xu; Namho Kim; Justin Hanes; Laura M Ensign
Journal:  Adv Drug Deliv Rev       Date:  2015-10-09       Impact factor: 15.470

Review 9.  Micro- and macrorheology of mucus.

Authors:  Samuel K Lai; Ying-Ying Wang; Denis Wirtz; Justin Hanes
Journal:  Adv Drug Deliv Rev       Date:  2009-01-03       Impact factor: 15.470

10.  A biophysical basis for mucus solids concentration as a candidate biomarker for airways disease.

Authors:  David B Hill; Paula A Vasquez; John Mellnik; Scott A McKinley; Aaron Vose; Frank Mu; Ashley G Henderson; Scott H Donaldson; Neil E Alexis; Richard C Boucher; M Gregory Forest
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

View more
  5 in total

1.  Reliably sourced airway mucus.

Authors:  Katherine Joyner; Gregg A Duncan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-09-11       Impact factor: 5.464

2.  Inhaled gene therapy of preclinical muco-obstructive lung diseases by nanoparticles capable of breaching the airway mucus barrier.

Authors:  Namho Kim; Gijung Kwak; Jason Rodriguez; Alessandra Livraghi-Butrico; Xinyuan Zuo; Valentina Simon; Eric Han; Siddharth Kaup Shenoy; Nikhil Pandey; Marina Mazur; Susan E Birket; Anthony Kim; Steven M Rowe; Richard Boucher; Justin Hanes; Jung Soo Suk
Journal:  Thorax       Date:  2021-10-25       Impact factor: 9.102

3.  MPTHub: An Open-Source Software for Characterizing the Transport of Particles in Biorelevant Media.

Authors:  Leandro Gabriel; Helena Almeida; Marta Avelar; Bruno Sarmento; José das Neves
Journal:  Nanomaterials (Basel)       Date:  2022-06-01       Impact factor: 5.719

Review 4.  Avoiding a Sticky Situation: Bypassing the Mucus Barrier for Improved Local Drug Delivery.

Authors:  Hannah C Zierden; Aditya Josyula; Rachel L Shapiro; Henry T Hsueh; Justin Hanes; Laura M Ensign
Journal:  Trends Mol Med       Date:  2021-01-04       Impact factor: 11.951

Review 5.  Enhancing nanoparticle penetration through airway mucus to improve drug delivery efficacy in the lung.

Authors:  Daiqin Chen; Jinhao Liu; Jerry Wu; Jung Soo Suk
Journal:  Expert Opin Drug Deliv       Date:  2020-12-07       Impact factor: 8.129

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.